Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients

The emergence of novel variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made it more difficult to prevent the virus from spreading despite available vaccines. Reports of breakthrough infections and decreased capacity of antibodies to neutralize variants raise the ques...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurme, Antti, Jalkanen, Pinja, Heroum, Jemna, Liedes, Oona, Vara, Saimi, Melin, Merit, Teräsjärvi, Johanna, He, Qiushui, Pöysti, Sakari, Hänninen, Arno, Oksi, Jarmo, Vuorinen, Tytti, Kantele, Anu, Tähtinen, Paula A., Ivaska, Lauri, Kakkola, Laura, Lempainen, Johanna, Julkunen, Ilkka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073085/
https://www.ncbi.nlm.nih.gov/pubmed/35529867
http://dx.doi.org/10.3389/fimmu.2022.869990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073085/
https://www.ncbi.nlm.nih.gov/pubmed/35529867
http://dx.doi.org/10.3389/fimmu.2022.869990

Ejemplares similares